WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Affiliated Programs

5.19.26

Conversation with Professor Robin Feldman: Artificial Intelligence and Intellectual Property
Wilson Sonsini is pleased to host INTRO Life Sciences.
WSGR Events

5.19.26

Building Patent Portfolio Value and Strategic Licensing Trends for In-House Counsel
Patent portfolios are under increasing pressure to do more than protect innovation. In today’s market, in-house legal teams are being asked to manage costs, support business growth, and think more strategically about how patent assets can create long-term value. That includes making smart decisions about portfolio development and pruning, while also understanding how licensing structures, acquisitions, and patent pools can help advance business goals and reduce risk. 
Affiliated Programs

2.10.26

Designing Medicines: The AI Revolution and NextGen Therapeutics
Wilson Sonsini is pleased to sponsor INTRO Life Sciences.
WSGR Events

6.13.24

Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
WSGR Events

8.24.21

Innovator’s Edge Series: Third-Party Intellectual Property and Disputes
Wilson Sonsini is pleased to present the Innovator’s Edge Series. Life sciences companies should be aware of the relevant intellectual property rights of competitors and other third parties, as infringement of such rights could lead to undesired outcomes, such as unwanted litigation, significant monetary payouts, or even shutdown of the company. This webinar will present important steps that can be taken to identify and reduce risks that arise from the patent rights of others.
WSGR Events

10.08.20

Innovator’s Edge Series: Identifying and Managing Existing and Potential IP Disputes with Third Parties
Intellectual property is one of the most valued assets of life science companies.  As such, founders can be strategic while planning to help minimize the risk of ever reaching the point of entering into an IP dispute. By identifying and managing potential IP disputes from the onset, companies can focus efforts on other growth matters, such as running a thriving business.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.